EE674 Cost-Effectiveness of Pemigatinib for Patients With Advanced Intrahepatic Cholangiocarcinoma and FGFR2 Fusions/Rearrangements: 2024 FIGHT-202 Trial Final Results
Abstract
Authors
WM Huang IT Wang HL Chen CH Chueh NJ Chiang YW Tsai